We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current ANTX market cap is 33.46M. The company's latest EPS is USD -2.1665 and P/E is -0.51.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -18.18M | -18.82M | -18.3M | -15.88M | -14.01M |
| Net Income | -16.71M | -16.9M | -16.62M | -14.44M | -12.75M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 |
| Operating Income | -21.57M | -42.26M | -69.64M |
| Net Income | -28.06M | -42.78M | -64.73M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Assets | 153.81M | 138.74M | 121.26M | 108.48M | 97.69M |
| Total Liabilities | 14.84M | 14.04M | 10.66M | 10.13M | 10.02M |
| Total Equity | 138.97M | 124.7M | 110.6M | 98.35M | 87.67M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 65.32M | 102.56M | 138.74M |
| Total Liabilities | 3.41M | 7.19M | 14.04M |
| Total Equity | -47.41M | 95.37M | 124.7M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Operating | -36.22M | -53.29M | -17.59M | -31.98M | -43.98M |
| Investing | -43.7M | -43.28M | 26.29M | 42.75M | 61.47M |
| Financing | 85.32M | 84.99M | 349k | 349k | 372k |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Operating | -20.48M | -33.46M | -53.29M |
| Investing | -50.02M | -21.77M | -43.28M |
| Financing | 78.54M | 70.36M | 84.99M |
| Market Cap | 33.46M |
| Price to Earnings Ratio | -0.51 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.12 |
| Price to Book Ratio | 0.27 |
| Dividend Yield | - |
| Shares Outstanding | 29.88M |
| Average Volume (1 week) | 179.21k |
| Average Volume (1 Month) | 134.61k |
| 52 Week Change | -71.72% |
| 52 Week High | 4.00 |
| 52 Week Low | 0.87 |
| Spread (Intraday) | 0.06 (5.31%) |
| Company Name | AN2 Therapeutics Inc |
| Address |
850 new burton road dover, delaware 19904 |
| Website | https://www.an2therapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
